Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Embio is a global pharmaceutical company specializing in the development and large-scale manufacturing of active pharmaceutical ingredients (APIs) and chiral intermediates. The company is recognized as one of the world's largest producers of Ephedrine and Pseudoephedrine salts, serving major pharmaceutical markets including the US, Europe, and Japan. Embio's core expertise lies in complex chemical synthesis and biotechnology-based fermentation processes, particularly in the production of chiral molecules. Beyond its leadership in respiratory and decongestant APIs, the company provides contract manufacturing services and develops advanced intermediates for various therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Embio.